retatrutide mechanism triple agonist gip glp-1 glucagon retatrutide What Is Retatrutide? The Peptide Explained retatrutide triple hormone receptor agonist

Despite these findings, a clear link has yet to be established, and much of the evidence remains inconsistent

Due to a short plasma half-life of native GLP-1, several synthesized GLP-1 receptor agonists (RAs) were developed for type 2 diabetes mellitus (DM) treatment

They are primarily used in the management of type 2 diabetes (T2D).

Did you know that individuals using semaglutide experience average weight reductions ranging from 9.6% to 17.4% of their initial body weight

Ozempic and other GLP-1 receptor agonists can increase insulin secretion, suppress glucagon release, slow digestion, and more

Gastrointestinal (GI) adverse eventsparticularly nausea, vomiting, diarrhea, and constipationare the most common side effects, generally emerging during dose escalation and resolving over time